SCHEMBL3156170

SCHEMBL3156170

CC(=O)NCCNc1cc(NCCNC(=O)/C=C/c2cccc(C#N)c2)nc(-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CLK4 Q9HAZ1 2/20 0.55
USP2 O75604 1/20 0.55
PIM2 Q9P1W9 1/20 0.51
ABCG2 Q9UNQ0 6/20 0.45
ABCB1 P08183 3/20 0.45
ABCC1 P33527 1/20 0.45
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
HDAC4 P56524 1/20 0.41
MEF2D Q14814 1/20 0.41
P4HB P07237 5/20 0.41
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156177 1.00 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3169453 0.92 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3169445 0.92 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3156047 0.89 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3156062 0.89 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3171042 0.88 PIM2 (0.54) CYP1A2CYP3A4CLK4PIM2ADORA2A
SCHEMBL3171072 0.88 PIM2 (0.54) CYP1A2CYP3A4CLK4PIM2ADORA2A
SCHEMBL3258039 0.84 USP2 (0.48) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3258045 0.84 USP2 (0.48) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3165800 0.83 ALDH1A1 (0.56) PIM2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed